nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—atherosclerosis	0.252	1	CbGaD
Meloxicam—ABCC4—Rosuvastatin—atherosclerosis	0.156	0.324	CbGbCtD
Meloxicam—CYP2C8—Simvastatin—atherosclerosis	0.0415	0.0862	CbGbCtD
Meloxicam—CYP2C8—Pravastatin—atherosclerosis	0.0406	0.0844	CbGbCtD
Meloxicam—CYP2C8—Lovastatin—atherosclerosis	0.0406	0.0844	CbGbCtD
Meloxicam—CYP2C9—Rosuvastatin—atherosclerosis	0.0311	0.0647	CbGbCtD
Meloxicam—CYP2C9—Simvastatin—atherosclerosis	0.0289	0.0601	CbGbCtD
Meloxicam—CYP2C9—Pravastatin—atherosclerosis	0.0283	0.0588	CbGbCtD
Meloxicam—CYP2C9—Lovastatin—atherosclerosis	0.0283	0.0588	CbGbCtD
Meloxicam—CYP3A4—Rosuvastatin—atherosclerosis	0.0181	0.0376	CbGbCtD
Meloxicam—CYP3A4—Ezetimibe—atherosclerosis	0.0181	0.0376	CbGbCtD
Meloxicam—CYP3A4—Simvastatin—atherosclerosis	0.0168	0.035	CbGbCtD
Meloxicam—CYP3A4—Pravastatin—atherosclerosis	0.0165	0.0342	CbGbCtD
Meloxicam—CYP3A4—Lovastatin—atherosclerosis	0.0165	0.0342	CbGbCtD
Meloxicam—PTGS2—leg—atherosclerosis	0.00165	0.103	CbGeAlD
Meloxicam—PTGS2—hindlimb—atherosclerosis	0.00147	0.0916	CbGeAlD
Meloxicam—PTGS2—appendage—atherosclerosis	0.00126	0.0786	CbGeAlD
Meloxicam—Lornoxicam—PTGS2—atherosclerosis	0.000967	0.341	CrCbGaD
Meloxicam—PTGS1—artery—atherosclerosis	0.000945	0.0588	CbGeAlD
Meloxicam—PTGS2—artery—atherosclerosis	0.000903	0.0562	CbGeAlD
Meloxicam—PGD—connective tissue—atherosclerosis	0.000901	0.056	CbGeAlD
Meloxicam—Tenoxicam—PTGS2—atherosclerosis	0.000862	0.304	CrCbGaD
Meloxicam—PTGS1—endothelium—atherosclerosis	0.000798	0.0496	CbGeAlD
Meloxicam—PGD—cardiovascular system—atherosclerosis	0.000784	0.0488	CbGeAlD
Meloxicam—PTGS2—endothelium—atherosclerosis	0.000763	0.0474	CbGeAlD
Meloxicam—PTGS1—blood vessel—atherosclerosis	0.000736	0.0458	CbGeAlD
Meloxicam—PTGS2—blood vessel—atherosclerosis	0.000703	0.0438	CbGeAlD
Meloxicam—PGD—adipose tissue—atherosclerosis	0.000691	0.043	CbGeAlD
Meloxicam—Piroxicam—PTGS2—atherosclerosis	0.000532	0.188	CrCbGaD
Meloxicam—ABCC4—adipose tissue—atherosclerosis	0.000492	0.0306	CbGeAlD
Meloxicam—PGD—liver—atherosclerosis	0.000485	0.0302	CbGeAlD
Meloxicam—Piroxicam—ALB—atherosclerosis	0.000474	0.167	CrCbGaD
Meloxicam—PTGS1—connective tissue—atherosclerosis	0.000377	0.0235	CbGeAlD
Meloxicam—PTGS2—connective tissue—atherosclerosis	0.000361	0.0224	CbGeAlD
Meloxicam—CYP2C9—cardiovascular system—atherosclerosis	0.00036	0.0224	CbGeAlD
Meloxicam—ABCC4—liver—atherosclerosis	0.000345	0.0215	CbGeAlD
Meloxicam—Erythema multiforme—Pravastatin—atherosclerosis	0.000337	0.00208	CcSEcCtD
Meloxicam—Dysgeusia—Simvastatin—atherosclerosis	0.000336	0.00208	CcSEcCtD
Meloxicam—Flushing—Niacin—atherosclerosis	0.000336	0.00207	CcSEcCtD
Meloxicam—Angioedema—Lovastatin—atherosclerosis	0.000335	0.00207	CcSEcCtD
Meloxicam—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000334	0.00206	CcSEcCtD
Meloxicam—Anaemia—Ezetimibe—atherosclerosis	0.000333	0.00205	CcSEcCtD
Meloxicam—Tinnitus—Pravastatin—atherosclerosis	0.000332	0.00205	CcSEcCtD
Meloxicam—Malaise—Lovastatin—atherosclerosis	0.000331	0.00204	CcSEcCtD
Meloxicam—Cardiac disorder—Pravastatin—atherosclerosis	0.000331	0.00204	CcSEcCtD
Meloxicam—Flushing—Pravastatin—atherosclerosis	0.000331	0.00204	CcSEcCtD
Meloxicam—Muscle spasms—Simvastatin—atherosclerosis	0.00033	0.00204	CcSEcCtD
Meloxicam—Vertigo—Lovastatin—atherosclerosis	0.00033	0.00204	CcSEcCtD
Meloxicam—Angioedema—Ezetimibe—atherosclerosis	0.000329	0.00203	CcSEcCtD
Meloxicam—Angiopathy—Niacin—atherosclerosis	0.000328	0.00203	CcSEcCtD
Meloxicam—Leukopenia—Lovastatin—atherosclerosis	0.000328	0.00203	CcSEcCtD
Meloxicam—PTGS1—cardiovascular system—atherosclerosis	0.000328	0.0204	CbGeAlD
Meloxicam—Malaise—Ezetimibe—atherosclerosis	0.000324	0.002	CcSEcCtD
Meloxicam—Vision blurred—Simvastatin—atherosclerosis	0.000323	0.002	CcSEcCtD
Meloxicam—Arrhythmia—Niacin—atherosclerosis	0.000323	0.002	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000322	0.00199	CcSEcCtD
Meloxicam—Tremor—Simvastatin—atherosclerosis	0.000321	0.00199	CcSEcCtD
Meloxicam—Alopecia—Niacin—atherosclerosis	0.00032	0.00198	CcSEcCtD
Meloxicam—Insomnia—Rosuvastatin—atherosclerosis	0.00032	0.00197	CcSEcCtD
Meloxicam—Ill-defined disorder—Simvastatin—atherosclerosis	0.000318	0.00197	CcSEcCtD
Meloxicam—Arrhythmia—Pravastatin—atherosclerosis	0.000318	0.00197	CcSEcCtD
Meloxicam—Palpitations—Ezetimibe—atherosclerosis	0.000318	0.00196	CcSEcCtD
Meloxicam—Paraesthesia—Rosuvastatin—atherosclerosis	0.000317	0.00196	CcSEcCtD
Meloxicam—Anaemia—Simvastatin—atherosclerosis	0.000317	0.00196	CcSEcCtD
Meloxicam—Erythema—Niacin—atherosclerosis	0.000315	0.00195	CcSEcCtD
Meloxicam—Malnutrition—Niacin—atherosclerosis	0.000315	0.00195	CcSEcCtD
Meloxicam—Alopecia—Pravastatin—atherosclerosis	0.000315	0.00194	CcSEcCtD
Meloxicam—Cough—Ezetimibe—atherosclerosis	0.000314	0.00194	CcSEcCtD
Meloxicam—PTGS2—cardiovascular system—atherosclerosis	0.000314	0.0195	CbGeAlD
Meloxicam—Angioedema—Simvastatin—atherosclerosis	0.000314	0.00194	CcSEcCtD
Meloxicam—Myalgia—Lovastatin—atherosclerosis	0.000312	0.00193	CcSEcCtD
Meloxicam—Arthralgia—Lovastatin—atherosclerosis	0.000312	0.00193	CcSEcCtD
Meloxicam—Anxiety—Lovastatin—atherosclerosis	0.000311	0.00192	CcSEcCtD
Meloxicam—Dyspepsia—Rosuvastatin—atherosclerosis	0.000311	0.00192	CcSEcCtD
Meloxicam—Hypertension—Ezetimibe—atherosclerosis	0.000311	0.00192	CcSEcCtD
Meloxicam—Flatulence—Niacin—atherosclerosis	0.00031	0.00192	CcSEcCtD
Meloxicam—Malaise—Simvastatin—atherosclerosis	0.000309	0.00191	CcSEcCtD
Meloxicam—Tension—Niacin—atherosclerosis	0.000309	0.00191	CcSEcCtD
Meloxicam—Discomfort—Lovastatin—atherosclerosis	0.000309	0.00191	CcSEcCtD
Meloxicam—Vertigo—Simvastatin—atherosclerosis	0.000308	0.0019	CcSEcCtD
Meloxicam—Leukopenia—Simvastatin—atherosclerosis	0.000307	0.0019	CcSEcCtD
Meloxicam—Arthralgia—Ezetimibe—atherosclerosis	0.000306	0.00189	CcSEcCtD
Meloxicam—Myalgia—Ezetimibe—atherosclerosis	0.000306	0.00189	CcSEcCtD
Meloxicam—Nervousness—Niacin—atherosclerosis	0.000306	0.00189	CcSEcCtD
Meloxicam—Flatulence—Pravastatin—atherosclerosis	0.000306	0.00189	CcSEcCtD
Meloxicam—Dry mouth—Lovastatin—atherosclerosis	0.000305	0.00189	CcSEcCtD
Meloxicam—Tension—Pravastatin—atherosclerosis	0.000304	0.00188	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000304	0.00188	CcSEcCtD
Meloxicam—Dysgeusia—Pravastatin—atherosclerosis	0.000304	0.00188	CcSEcCtD
Meloxicam—Muscle spasms—Niacin—atherosclerosis	0.000303	0.00187	CcSEcCtD
Meloxicam—Discomfort—Ezetimibe—atherosclerosis	0.000303	0.00187	CcSEcCtD
Meloxicam—Pain—Rosuvastatin—atherosclerosis	0.000302	0.00187	CcSEcCtD
Meloxicam—Constipation—Rosuvastatin—atherosclerosis	0.000302	0.00187	CcSEcCtD
Meloxicam—Confusional state—Lovastatin—atherosclerosis	0.000302	0.00186	CcSEcCtD
Meloxicam—Nervousness—Pravastatin—atherosclerosis	0.000301	0.00186	CcSEcCtD
Meloxicam—Dry mouth—Ezetimibe—atherosclerosis	0.0003	0.00185	CcSEcCtD
Meloxicam—Anaphylactic shock—Lovastatin—atherosclerosis	0.000299	0.00185	CcSEcCtD
Meloxicam—Muscle spasms—Pravastatin—atherosclerosis	0.000298	0.00184	CcSEcCtD
Meloxicam—Infection—Lovastatin—atherosclerosis	0.000297	0.00184	CcSEcCtD
Meloxicam—Vision blurred—Niacin—atherosclerosis	0.000297	0.00183	CcSEcCtD
Meloxicam—Confusional state—Ezetimibe—atherosclerosis	0.000296	0.00183	CcSEcCtD
Meloxicam—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000294	0.00181	CcSEcCtD
Meloxicam—Thrombocytopenia—Lovastatin—atherosclerosis	0.000293	0.00181	CcSEcCtD
Meloxicam—Vision blurred—Pravastatin—atherosclerosis	0.000292	0.00181	CcSEcCtD
Meloxicam—Arthralgia—Simvastatin—atherosclerosis	0.000292	0.0018	CcSEcCtD
Meloxicam—Myalgia—Simvastatin—atherosclerosis	0.000292	0.0018	CcSEcCtD
Meloxicam—Infection—Ezetimibe—atherosclerosis	0.000292	0.0018	CcSEcCtD
Meloxicam—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000291	0.0018	CcSEcCtD
Meloxicam—Anxiety—Simvastatin—atherosclerosis	0.000291	0.0018	CcSEcCtD
Meloxicam—Tremor—Pravastatin—atherosclerosis	0.000291	0.0018	CcSEcCtD
Meloxicam—PTGS1—adipose tissue—atherosclerosis	0.000289	0.018	CbGeAlD
Meloxicam—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000289	0.00178	CcSEcCtD
Meloxicam—Discomfort—Simvastatin—atherosclerosis	0.000289	0.00178	CcSEcCtD
Meloxicam—Nervous system disorder—Ezetimibe—atherosclerosis	0.000288	0.00178	CcSEcCtD
Meloxicam—Angioedema—Niacin—atherosclerosis	0.000288	0.00178	CcSEcCtD
Meloxicam—Ill-defined disorder—Pravastatin—atherosclerosis	0.000288	0.00178	CcSEcCtD
Meloxicam—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000288	0.00178	CcSEcCtD
Meloxicam—Anaemia—Pravastatin—atherosclerosis	0.000287	0.00177	CcSEcCtD
Meloxicam—Skin disorder—Ezetimibe—atherosclerosis	0.000285	0.00176	CcSEcCtD
Meloxicam—Angioedema—Pravastatin—atherosclerosis	0.000283	0.00175	CcSEcCtD
Meloxicam—Vertigo—Niacin—atherosclerosis	0.000283	0.00175	CcSEcCtD
Meloxicam—Syncope—Niacin—atherosclerosis	0.000283	0.00175	CcSEcCtD
Meloxicam—Confusional state—Simvastatin—atherosclerosis	0.000282	0.00174	CcSEcCtD
Meloxicam—Leukopenia—Niacin—atherosclerosis	0.000282	0.00174	CcSEcCtD
Meloxicam—Urticaria—Rosuvastatin—atherosclerosis	0.000281	0.00173	CcSEcCtD
Meloxicam—Oedema—Simvastatin—atherosclerosis	0.00028	0.00173	CcSEcCtD
Meloxicam—Anaphylactic shock—Simvastatin—atherosclerosis	0.00028	0.00173	CcSEcCtD
Meloxicam—Malaise—Pravastatin—atherosclerosis	0.00028	0.00173	CcSEcCtD
Meloxicam—Abdominal pain—Rosuvastatin—atherosclerosis	0.000279	0.00172	CcSEcCtD
Meloxicam—Vertigo—Pravastatin—atherosclerosis	0.000279	0.00172	CcSEcCtD
Meloxicam—Palpitations—Niacin—atherosclerosis	0.000278	0.00172	CcSEcCtD
Meloxicam—Infection—Simvastatin—atherosclerosis	0.000278	0.00172	CcSEcCtD
Meloxicam—Leukopenia—Pravastatin—atherosclerosis	0.000278	0.00171	CcSEcCtD
Meloxicam—Loss of consciousness—Niacin—atherosclerosis	0.000277	0.00171	CcSEcCtD
Meloxicam—PTGS2—adipose tissue—atherosclerosis	0.000277	0.0172	CbGeAlD
Meloxicam—Cough—Niacin—atherosclerosis	0.000275	0.0017	CcSEcCtD
Meloxicam—Thrombocytopenia—Simvastatin—atherosclerosis	0.000274	0.00169	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000273	0.00168	CcSEcCtD
Meloxicam—Insomnia—Lovastatin—atherosclerosis	0.000271	0.00167	CcSEcCtD
Meloxicam—Cough—Pravastatin—atherosclerosis	0.000271	0.00167	CcSEcCtD
Meloxicam—Paraesthesia—Lovastatin—atherosclerosis	0.000269	0.00166	CcSEcCtD
Meloxicam—Arthralgia—Niacin—atherosclerosis	0.000268	0.00166	CcSEcCtD
Meloxicam—Myalgia—Niacin—atherosclerosis	0.000268	0.00166	CcSEcCtD
Meloxicam—Hypertension—Pravastatin—atherosclerosis	0.000268	0.00165	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000268	0.00165	CcSEcCtD
Meloxicam—Dyspnoea—Lovastatin—atherosclerosis	0.000267	0.00165	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000266	0.00165	CcSEcCtD
Meloxicam—Insomnia—Ezetimibe—atherosclerosis	0.000266	0.00164	CcSEcCtD
Meloxicam—Myalgia—Pravastatin—atherosclerosis	0.000264	0.00163	CcSEcCtD
Meloxicam—Arthralgia—Pravastatin—atherosclerosis	0.000264	0.00163	CcSEcCtD
Meloxicam—Paraesthesia—Ezetimibe—atherosclerosis	0.000264	0.00163	CcSEcCtD
Meloxicam—Dyspepsia—Lovastatin—atherosclerosis	0.000264	0.00163	CcSEcCtD
Meloxicam—Anxiety—Pravastatin—atherosclerosis	0.000263	0.00163	CcSEcCtD
Meloxicam—Dry mouth—Niacin—atherosclerosis	0.000262	0.00162	CcSEcCtD
Meloxicam—Dyspnoea—Ezetimibe—atherosclerosis	0.000262	0.00162	CcSEcCtD
Meloxicam—Discomfort—Pravastatin—atherosclerosis	0.000261	0.00161	CcSEcCtD
Meloxicam—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00026	0.00161	CcSEcCtD
Meloxicam—Decreased appetite—Lovastatin—atherosclerosis	0.00026	0.00161	CcSEcCtD
Meloxicam—Dyspepsia—Ezetimibe—atherosclerosis	0.000258	0.0016	CcSEcCtD
Meloxicam—Fatigue—Lovastatin—atherosclerosis	0.000258	0.00159	CcSEcCtD
Meloxicam—Oedema—Niacin—atherosclerosis	0.000257	0.00159	CcSEcCtD
Meloxicam—Anaphylactic shock—Niacin—atherosclerosis	0.000257	0.00159	CcSEcCtD
Meloxicam—Constipation—Lovastatin—atherosclerosis	0.000256	0.00158	CcSEcCtD
Meloxicam—Pain—Lovastatin—atherosclerosis	0.000256	0.00158	CcSEcCtD
Meloxicam—Confusional state—Pravastatin—atherosclerosis	0.000255	0.00158	CcSEcCtD
Meloxicam—Decreased appetite—Ezetimibe—atherosclerosis	0.000255	0.00158	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000255	0.00158	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000254	0.00157	CcSEcCtD
Meloxicam—Asthenia—Rosuvastatin—atherosclerosis	0.000253	0.00157	CcSEcCtD
Meloxicam—Insomnia—Simvastatin—atherosclerosis	0.000253	0.00156	CcSEcCtD
Meloxicam—Oedema—Pravastatin—atherosclerosis	0.000253	0.00156	CcSEcCtD
Meloxicam—Anaphylactic shock—Pravastatin—atherosclerosis	0.000253	0.00156	CcSEcCtD
Meloxicam—Fatigue—Ezetimibe—atherosclerosis	0.000253	0.00156	CcSEcCtD
Meloxicam—Shock—Niacin—atherosclerosis	0.000253	0.00156	CcSEcCtD
Meloxicam—Infection—Pravastatin—atherosclerosis	0.000252	0.00155	CcSEcCtD
Meloxicam—Paraesthesia—Simvastatin—atherosclerosis	0.000251	0.00155	CcSEcCtD
Meloxicam—Pain—Ezetimibe—atherosclerosis	0.000251	0.00155	CcSEcCtD
Meloxicam—Constipation—Ezetimibe—atherosclerosis	0.000251	0.00155	CcSEcCtD
Meloxicam—Tachycardia—Niacin—atherosclerosis	0.000251	0.00155	CcSEcCtD
Meloxicam—CYP2C8—liver—atherosclerosis	0.00025	0.0156	CbGeAlD
Meloxicam—Pruritus—Rosuvastatin—atherosclerosis	0.00025	0.00154	CcSEcCtD
Meloxicam—Skin disorder—Niacin—atherosclerosis	0.00025	0.00154	CcSEcCtD
Meloxicam—Dyspnoea—Simvastatin—atherosclerosis	0.00025	0.00154	CcSEcCtD
Meloxicam—Hyperhidrosis—Niacin—atherosclerosis	0.000249	0.00154	CcSEcCtD
Meloxicam—Thrombocytopenia—Pravastatin—atherosclerosis	0.000248	0.00153	CcSEcCtD
Meloxicam—Feeling abnormal—Lovastatin—atherosclerosis	0.000247	0.00152	CcSEcCtD
Meloxicam—Dyspepsia—Simvastatin—atherosclerosis	0.000246	0.00152	CcSEcCtD
Meloxicam—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000245	0.00151	CcSEcCtD
Meloxicam—Hyperhidrosis—Pravastatin—atherosclerosis	0.000245	0.00151	CcSEcCtD
Meloxicam—Decreased appetite—Simvastatin—atherosclerosis	0.000243	0.0015	CcSEcCtD
Meloxicam—Feeling abnormal—Ezetimibe—atherosclerosis	0.000242	0.00149	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000242	0.00149	CcSEcCtD
Meloxicam—Diarrhoea—Rosuvastatin—atherosclerosis	0.000242	0.00149	CcSEcCtD
Meloxicam—Fatigue—Simvastatin—atherosclerosis	0.000241	0.00149	CcSEcCtD
Meloxicam—Hypotension—Niacin—atherosclerosis	0.00024	0.00148	CcSEcCtD
Meloxicam—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00024	0.00148	CcSEcCtD
Meloxicam—Constipation—Simvastatin—atherosclerosis	0.000239	0.00148	CcSEcCtD
Meloxicam—Pain—Simvastatin—atherosclerosis	0.000239	0.00148	CcSEcCtD
Meloxicam—Urticaria—Lovastatin—atherosclerosis	0.000238	0.00147	CcSEcCtD
Meloxicam—Abdominal pain—Lovastatin—atherosclerosis	0.000237	0.00146	CcSEcCtD
Meloxicam—Body temperature increased—Lovastatin—atherosclerosis	0.000237	0.00146	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000234	0.00145	CcSEcCtD
Meloxicam—Dizziness—Rosuvastatin—atherosclerosis	0.000234	0.00144	CcSEcCtD
Meloxicam—Urticaria—Ezetimibe—atherosclerosis	0.000233	0.00144	CcSEcCtD
Meloxicam—Insomnia—Niacin—atherosclerosis	0.000233	0.00144	CcSEcCtD
Meloxicam—Abdominal pain—Ezetimibe—atherosclerosis	0.000232	0.00143	CcSEcCtD
Meloxicam—Body temperature increased—Ezetimibe—atherosclerosis	0.000232	0.00143	CcSEcCtD
Meloxicam—Paraesthesia—Niacin—atherosclerosis	0.000231	0.00143	CcSEcCtD
Meloxicam—Feeling abnormal—Simvastatin—atherosclerosis	0.000231	0.00143	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000231	0.00142	CcSEcCtD
Meloxicam—Dyspnoea—Niacin—atherosclerosis	0.000229	0.00142	CcSEcCtD
Meloxicam—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000229	0.00141	CcSEcCtD
Meloxicam—Insomnia—Pravastatin—atherosclerosis	0.000229	0.00141	CcSEcCtD
Meloxicam—Somnolence—Niacin—atherosclerosis	0.000229	0.00141	CcSEcCtD
Meloxicam—Paraesthesia—Pravastatin—atherosclerosis	0.000227	0.0014	CcSEcCtD
Meloxicam—Dyspepsia—Niacin—atherosclerosis	0.000226	0.0014	CcSEcCtD
Meloxicam—Dyspnoea—Pravastatin—atherosclerosis	0.000226	0.00139	CcSEcCtD
Meloxicam—Decreased appetite—Niacin—atherosclerosis	0.000224	0.00138	CcSEcCtD
Meloxicam—Dyspepsia—Pravastatin—atherosclerosis	0.000223	0.00138	CcSEcCtD
Meloxicam—Rash—Rosuvastatin—atherosclerosis	0.000223	0.00138	CcSEcCtD
Meloxicam—Dermatitis—Rosuvastatin—atherosclerosis	0.000223	0.00137	CcSEcCtD
Meloxicam—Urticaria—Simvastatin—atherosclerosis	0.000222	0.00137	CcSEcCtD
Meloxicam—CYP2C9—liver—atherosclerosis	0.000222	0.0138	CbGeAlD
Meloxicam—Gastrointestinal disorder—Niacin—atherosclerosis	0.000222	0.00137	CcSEcCtD
Meloxicam—Body temperature increased—Simvastatin—atherosclerosis	0.000221	0.00137	CcSEcCtD
Meloxicam—Abdominal pain—Simvastatin—atherosclerosis	0.000221	0.00137	CcSEcCtD
Meloxicam—Headache—Rosuvastatin—atherosclerosis	0.000221	0.00137	CcSEcCtD
Meloxicam—Hypersensitivity—Lovastatin—atherosclerosis	0.000221	0.00136	CcSEcCtD
Meloxicam—Decreased appetite—Pravastatin—atherosclerosis	0.00022	0.00136	CcSEcCtD
Meloxicam—Pain—Niacin—atherosclerosis	0.00022	0.00136	CcSEcCtD
Meloxicam—Fatigue—Pravastatin—atherosclerosis	0.000218	0.00135	CcSEcCtD
Meloxicam—Pain—Pravastatin—atherosclerosis	0.000216	0.00134	CcSEcCtD
Meloxicam—Constipation—Pravastatin—atherosclerosis	0.000216	0.00134	CcSEcCtD
Meloxicam—Hypersensitivity—Ezetimibe—atherosclerosis	0.000216	0.00134	CcSEcCtD
Meloxicam—Asthenia—Lovastatin—atherosclerosis	0.000215	0.00133	CcSEcCtD
Meloxicam—Pruritus—Lovastatin—atherosclerosis	0.000212	0.00131	CcSEcCtD
Meloxicam—Asthenia—Ezetimibe—atherosclerosis	0.000211	0.0013	CcSEcCtD
Meloxicam—Gastrointestinal pain—Niacin—atherosclerosis	0.00021	0.0013	CcSEcCtD
Meloxicam—Nausea—Rosuvastatin—atherosclerosis	0.00021	0.0013	CcSEcCtD
Meloxicam—Feeling abnormal—Pravastatin—atherosclerosis	0.000209	0.00129	CcSEcCtD
Meloxicam—Pruritus—Ezetimibe—atherosclerosis	0.000208	0.00128	CcSEcCtD
Meloxicam—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000207	0.00128	CcSEcCtD
Meloxicam—Hypersensitivity—Simvastatin—atherosclerosis	0.000206	0.00127	CcSEcCtD
Meloxicam—Diarrhoea—Lovastatin—atherosclerosis	0.000205	0.00127	CcSEcCtD
Meloxicam—Urticaria—Niacin—atherosclerosis	0.000204	0.00126	CcSEcCtD
Meloxicam—Abdominal pain—Niacin—atherosclerosis	0.000203	0.00126	CcSEcCtD
Meloxicam—Body temperature increased—Niacin—atherosclerosis	0.000203	0.00126	CcSEcCtD
Meloxicam—Urticaria—Pravastatin—atherosclerosis	0.000201	0.00124	CcSEcCtD
Meloxicam—Asthenia—Simvastatin—atherosclerosis	0.000201	0.00124	CcSEcCtD
Meloxicam—Diarrhoea—Ezetimibe—atherosclerosis	0.000201	0.00124	CcSEcCtD
Meloxicam—Body temperature increased—Pravastatin—atherosclerosis	0.0002	0.00124	CcSEcCtD
Meloxicam—Abdominal pain—Pravastatin—atherosclerosis	0.0002	0.00124	CcSEcCtD
Meloxicam—Pruritus—Simvastatin—atherosclerosis	0.000198	0.00122	CcSEcCtD
Meloxicam—Dizziness—Lovastatin—atherosclerosis	0.000198	0.00122	CcSEcCtD
Meloxicam—Dizziness—Ezetimibe—atherosclerosis	0.000194	0.0012	CcSEcCtD
Meloxicam—PTGS2—liver—atherosclerosis	0.000194	0.0121	CbGeAlD
Meloxicam—Diarrhoea—Simvastatin—atherosclerosis	0.000192	0.00118	CcSEcCtD
Meloxicam—Vomiting—Lovastatin—atherosclerosis	0.00019	0.00118	CcSEcCtD
Meloxicam—Hypersensitivity—Niacin—atherosclerosis	0.000189	0.00117	CcSEcCtD
Meloxicam—Rash—Lovastatin—atherosclerosis	0.000189	0.00117	CcSEcCtD
Meloxicam—Dermatitis—Lovastatin—atherosclerosis	0.000189	0.00116	CcSEcCtD
Meloxicam—Headache—Lovastatin—atherosclerosis	0.000188	0.00116	CcSEcCtD
Meloxicam—Vomiting—Ezetimibe—atherosclerosis	0.000187	0.00115	CcSEcCtD
Meloxicam—Hypersensitivity—Pravastatin—atherosclerosis	0.000187	0.00115	CcSEcCtD
Meloxicam—Dizziness—Simvastatin—atherosclerosis	0.000185	0.00114	CcSEcCtD
Meloxicam—Rash—Ezetimibe—atherosclerosis	0.000185	0.00114	CcSEcCtD
Meloxicam—Dermatitis—Ezetimibe—atherosclerosis	0.000185	0.00114	CcSEcCtD
Meloxicam—Asthenia—Niacin—atherosclerosis	0.000184	0.00114	CcSEcCtD
Meloxicam—Headache—Ezetimibe—atherosclerosis	0.000184	0.00114	CcSEcCtD
Meloxicam—Pruritus—Niacin—atherosclerosis	0.000182	0.00112	CcSEcCtD
Meloxicam—Asthenia—Pravastatin—atherosclerosis	0.000182	0.00112	CcSEcCtD
Meloxicam—Pruritus—Pravastatin—atherosclerosis	0.000179	0.00111	CcSEcCtD
Meloxicam—Vomiting—Simvastatin—atherosclerosis	0.000178	0.0011	CcSEcCtD
Meloxicam—Nausea—Lovastatin—atherosclerosis	0.000178	0.0011	CcSEcCtD
Meloxicam—Rash—Simvastatin—atherosclerosis	0.000177	0.00109	CcSEcCtD
Meloxicam—Dermatitis—Simvastatin—atherosclerosis	0.000176	0.00109	CcSEcCtD
Meloxicam—Diarrhoea—Niacin—atherosclerosis	0.000176	0.00109	CcSEcCtD
Meloxicam—Headache—Simvastatin—atherosclerosis	0.000175	0.00108	CcSEcCtD
Meloxicam—Nausea—Ezetimibe—atherosclerosis	0.000174	0.00108	CcSEcCtD
Meloxicam—Diarrhoea—Pravastatin—atherosclerosis	0.000173	0.00107	CcSEcCtD
Meloxicam—Dizziness—Niacin—atherosclerosis	0.00017	0.00105	CcSEcCtD
Meloxicam—CYP3A4—liver—atherosclerosis	0.00017	0.0105	CbGeAlD
Meloxicam—Dizziness—Pravastatin—atherosclerosis	0.000167	0.00103	CcSEcCtD
Meloxicam—Nausea—Simvastatin—atherosclerosis	0.000166	0.00103	CcSEcCtD
Meloxicam—Vomiting—Niacin—atherosclerosis	0.000163	0.00101	CcSEcCtD
Meloxicam—Rash—Niacin—atherosclerosis	0.000162	0.001	CcSEcCtD
Meloxicam—Dermatitis—Niacin—atherosclerosis	0.000162	0.001	CcSEcCtD
Meloxicam—Headache—Niacin—atherosclerosis	0.000161	0.000995	CcSEcCtD
Meloxicam—Vomiting—Pravastatin—atherosclerosis	0.000161	0.000994	CcSEcCtD
Meloxicam—Rash—Pravastatin—atherosclerosis	0.00016	0.000986	CcSEcCtD
Meloxicam—Dermatitis—Pravastatin—atherosclerosis	0.000159	0.000985	CcSEcCtD
Meloxicam—Headache—Pravastatin—atherosclerosis	0.000159	0.00098	CcSEcCtD
Meloxicam—Nausea—Niacin—atherosclerosis	0.000153	0.000943	CcSEcCtD
Meloxicam—Nausea—Pravastatin—atherosclerosis	0.00015	0.000929	CcSEcCtD
Meloxicam—PTGS2—Metabolism—BGN—atherosclerosis	1.98e-05	0.00023	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—atherosclerosis	1.98e-05	0.00023	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CETP—atherosclerosis	1.97e-05	0.00023	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.96e-05	0.000229	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOA5—atherosclerosis	1.96e-05	0.000228	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NAMPT—atherosclerosis	1.95e-05	0.000227	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOC3—atherosclerosis	1.93e-05	0.000224	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LDLR—atherosclerosis	1.91e-05	0.000223	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.9e-05	0.000221	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.9e-05	0.000221	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SCARB1—atherosclerosis	1.89e-05	0.00022	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PLA2G1B—atherosclerosis	1.89e-05	0.000219	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.88e-05	0.000218	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK3—atherosclerosis	1.87e-05	0.000218	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.86e-05	0.000217	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HSPA1B—atherosclerosis	1.85e-05	0.000215	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.85e-05	0.000215	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.84e-05	0.000214	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.84e-05	0.000214	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP27A1—atherosclerosis	1.84e-05	0.000214	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.83e-05	0.000213	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALOX5—atherosclerosis	1.82e-05	0.000212	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—atherosclerosis	1.81e-05	0.000211	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.81e-05	0.000211	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NCF1—atherosclerosis	1.79e-05	0.000208	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.79e-05	0.000208	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HMGCR—atherosclerosis	1.78e-05	0.000208	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.77e-05	0.000205	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	1.74e-05	0.000203	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOA2—atherosclerosis	1.74e-05	0.000203	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALOX15—atherosclerosis	1.74e-05	0.000203	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	1.74e-05	0.000203	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.72e-05	0.0002	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.72e-05	0.0002	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLTP—atherosclerosis	1.72e-05	0.0002	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CYBA—atherosclerosis	1.68e-05	0.000196	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.68e-05	0.000196	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FABP4—atherosclerosis	1.68e-05	0.000195	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LCAT—atherosclerosis	1.68e-05	0.000195	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LPA—atherosclerosis	1.66e-05	0.000193	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—atherosclerosis	1.66e-05	0.000193	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PARP1—atherosclerosis	1.65e-05	0.000192	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOA4—atherosclerosis	1.65e-05	0.000192	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NAMPT—atherosclerosis	1.63e-05	0.00019	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.62e-05	0.000189	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—LIPC—atherosclerosis	1.62e-05	0.000189	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.62e-05	0.000188	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOC3—atherosclerosis	1.61e-05	0.000188	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BGN—atherosclerosis	1.61e-05	0.000187	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.61e-05	0.000187	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—LDLR—atherosclerosis	1.6e-05	0.000187	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.6e-05	0.000186	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOA5—atherosclerosis	1.59e-05	0.000185	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCA1—atherosclerosis	1.59e-05	0.000185	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CETP—atherosclerosis	1.57e-05	0.000182	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.55e-05	0.00018	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.54e-05	0.000179	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.54e-05	0.000179	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.53e-05	0.000179	CbGpPWpGaD
Meloxicam—PGD—Disease—AKT1—atherosclerosis	1.53e-05	0.000178	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.52e-05	0.000177	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.5e-05	0.000175	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SCARB1—atherosclerosis	1.5e-05	0.000174	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.5e-05	0.000174	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.5e-05	0.000174	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.49e-05	0.000173	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.49e-05	0.000173	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.48e-05	0.000172	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.47e-05	0.000171	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.46e-05	0.00017	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.44e-05	0.000167	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOA2—atherosclerosis	1.42e-05	0.000165	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.42e-05	0.000165	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.42e-05	0.000165	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.42e-05	0.000165	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HMGCR—atherosclerosis	1.42e-05	0.000165	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.4e-05	0.000163	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.4e-05	0.000163	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.37e-05	0.000159	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HMOX1—atherosclerosis	1.36e-05	0.000159	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LPA—atherosclerosis	1.35e-05	0.000157	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.33e-05	0.000155	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.32e-05	0.000154	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LIPC—atherosclerosis	1.32e-05	0.000154	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOC3—atherosclerosis	1.31e-05	0.000153	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BGN—atherosclerosis	1.31e-05	0.000152	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOB—atherosclerosis	1.31e-05	0.000152	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LDLR—atherosclerosis	1.3e-05	0.000152	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.3e-05	0.000151	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOA5—atherosclerosis	1.3e-05	0.000151	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—atherosclerosis	1.28e-05	0.000149	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CETP—atherosclerosis	1.27e-05	0.000148	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—atherosclerosis	1.27e-05	0.000148	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCA1—atherosclerosis	1.26e-05	0.000147	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—atherosclerosis	1.26e-05	0.000147	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.26e-05	0.000147	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.25e-05	0.000145	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—LPL—atherosclerosis	1.25e-05	0.000145	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOB—atherosclerosis	1.24e-05	0.000144	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.23e-05	0.000144	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.22e-05	0.000142	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.22e-05	0.000142	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.22e-05	0.000142	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GPX1—atherosclerosis	1.22e-05	0.000142	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.21e-05	0.00014	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.19e-05	0.000138	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CD36—atherosclerosis	1.19e-05	0.000138	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LPL—atherosclerosis	1.18e-05	0.000138	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.18e-05	0.000137	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.15e-05	0.000134	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PRKCG—atherosclerosis	1.15e-05	0.000134	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MTHFR—atherosclerosis	1.12e-05	0.000131	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.11e-05	0.00013	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FABP4—atherosclerosis	1.11e-05	0.000129	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LCAT—atherosclerosis	1.11e-05	0.000129	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARA—atherosclerosis	1.1e-05	0.000128	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOA4—atherosclerosis	1.09e-05	0.000126	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HMOX1—atherosclerosis	1.08e-05	0.000126	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.08e-05	0.000126	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.08e-05	0.000125	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LIPC—atherosclerosis	1.07e-05	0.000125	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOC3—atherosclerosis	1.07e-05	0.000124	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.07e-05	0.000124	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AGT—atherosclerosis	1.07e-05	0.000124	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTHFR—atherosclerosis	1.06e-05	0.000124	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LDLR—atherosclerosis	1.06e-05	0.000124	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOE—atherosclerosis	1.05e-05	0.000122	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.04e-05	0.000121	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOB—atherosclerosis	1.04e-05	0.000121	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CETP—atherosclerosis	1.04e-05	0.000121	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PDGFB—atherosclerosis	1.04e-05	0.000121	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CAV1—atherosclerosis	1.04e-05	0.000121	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOA1—atherosclerosis	1.03e-05	0.00012	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.03e-05	0.00012	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.000117	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SCARB1—atherosclerosis	9.93e-06	0.000116	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOE—atherosclerosis	9.91e-06	0.000115	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—LPL—atherosclerosis	9.9e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.87e-06	0.000115	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CAV1—atherosclerosis	9.82e-06	0.000114	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOA1—atherosclerosis	9.8e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.67e-06	0.000113	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GPX1—atherosclerosis	9.66e-06	0.000112	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CG—atherosclerosis	9.44e-06	0.00011	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CD36—atherosclerosis	9.41e-06	0.00011	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMGCR—atherosclerosis	9.38e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOA2—atherosclerosis	9.35e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.35e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.35e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.35e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.24e-06	0.000108	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS2—atherosclerosis	9.24e-06	0.000107	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—atherosclerosis	9.11e-06	0.000106	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—INS—atherosclerosis	8.93e-06	0.000104	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LPA—atherosclerosis	8.92e-06	0.000104	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MTHFR—atherosclerosis	8.92e-06	0.000104	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMOX1—atherosclerosis	8.81e-06	0.000103	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARA—atherosclerosis	8.75e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BGN—atherosclerosis	8.64e-06	0.000101	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOA5—atherosclerosis	8.55e-06	9.95e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AGT—atherosclerosis	8.47e-06	9.86e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—INS—atherosclerosis	8.47e-06	9.85e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.46e-06	9.84e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOB—atherosclerosis	8.44e-06	9.82e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.36e-06	9.73e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOE—atherosclerosis	8.3e-06	9.66e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.23e-06	9.58e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CAV1—atherosclerosis	8.23e-06	9.57e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.21e-06	9.55e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOA1—atherosclerosis	8.21e-06	9.55e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—atherosclerosis	8.19e-06	9.53e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LPL—atherosclerosis	8.06e-06	9.38e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.95e-06	9.25e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GPX1—atherosclerosis	7.86e-06	9.15e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NOS3—atherosclerosis	7.83e-06	9.12e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SERPINE1—atherosclerosis	7.78e-06	9.05e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CD36—atherosclerosis	7.66e-06	8.91e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CG—atherosclerosis	7.49e-06	8.72e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS3—atherosclerosis	7.43e-06	8.64e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.26e-06	8.44e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—atherosclerosis	7.23e-06	8.41e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.17e-06	8.34e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—atherosclerosis	7.17e-06	8.34e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.13e-06	8.3e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARA—atherosclerosis	7.12e-06	8.28e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—INS—atherosclerosis	7.09e-06	8.25e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LIPC—atherosclerosis	7.09e-06	8.25e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOC3—atherosclerosis	7.04e-06	8.2e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LDLR—atherosclerosis	7e-06	8.15e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AGT—atherosclerosis	6.89e-06	8.02e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOB—atherosclerosis	6.87e-06	7.99e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CETP—atherosclerosis	6.84e-06	7.96e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOE—atherosclerosis	6.75e-06	7.86e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CAV1—atherosclerosis	6.69e-06	7.79e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.68e-06	7.78e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOA1—atherosclerosis	6.68e-06	7.77e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LPL—atherosclerosis	6.56e-06	7.63e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.55e-06	7.62e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—atherosclerosis	6.5e-06	7.57e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GPX1—atherosclerosis	6.4e-06	7.45e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CD36—atherosclerosis	6.23e-06	7.25e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NOS3—atherosclerosis	6.22e-06	7.24e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.18e-06	7.2e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.1e-06	7.09e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTHFR—atherosclerosis	5.91e-06	6.87e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—atherosclerosis	5.88e-06	6.85e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARA—atherosclerosis	5.79e-06	6.74e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—INS—atherosclerosis	5.77e-06	6.72e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AGT—atherosclerosis	5.61e-06	6.53e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.51e-06	6.41e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOE—atherosclerosis	5.5e-06	6.4e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CAV1—atherosclerosis	5.45e-06	6.34e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOA1—atherosclerosis	5.43e-06	6.32e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—atherosclerosis	5.3e-06	6.16e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—atherosclerosis	5.29e-06	6.16e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK3—atherosclerosis	5.06e-06	5.89e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NOS3—atherosclerosis	5.06e-06	5.89e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.96e-06	5.77e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—atherosclerosis	4.91e-06	5.71e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—atherosclerosis	4.79e-06	5.57e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.73e-06	5.5e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—INS—atherosclerosis	4.7e-06	5.47e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.63e-06	5.39e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOB—atherosclerosis	4.53e-06	5.27e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.41e-06	5.13e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LPL—atherosclerosis	4.33e-06	5.03e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—atherosclerosis	4.31e-06	5.01e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GPX1—atherosclerosis	4.22e-06	4.91e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NOS3—atherosclerosis	4.12e-06	4.79e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CD36—atherosclerosis	4.11e-06	4.78e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.89e-06	4.53e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARA—atherosclerosis	3.82e-06	4.45e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.77e-06	4.38e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AGT—atherosclerosis	3.7e-06	4.31e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—atherosclerosis	3.7e-06	4.31e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOE—atherosclerosis	3.63e-06	4.22e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—atherosclerosis	3.6e-06	4.19e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CAV1—atherosclerosis	3.59e-06	4.18e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOA1—atherosclerosis	3.58e-06	4.17e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—atherosclerosis	3.41e-06	3.97e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.27e-06	3.81e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—atherosclerosis	3.16e-06	3.67e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—INS—atherosclerosis	3.1e-06	3.6e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—atherosclerosis	2.86e-06	3.33e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—atherosclerosis	2.84e-06	3.3e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NOS3—atherosclerosis	2.72e-06	3.16e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.48e-06	2.89e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—atherosclerosis	2.33e-06	2.71e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—atherosclerosis	1.89e-06	2.2e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—atherosclerosis	1.25e-06	1.45e-05	CbGpPWpGaD
